SABCS: Omission of SLNB Safe in Clinically T1-2 Node-Negative Breast Cancer

HealthDay News — For patients with clinically T1-2 node-negative (cN0) breast cancer, the omission of sentinel lymph node biopsy (SLNB) results in noninferior five-year regional recurrence rates (RR) and regional…